ArticleTherapeutic advances in gastroenterology2017

Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial.

Brooks D Cash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.